Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies Reineke EL; Kao HYInt J Biol Sci 2009[May]; 5 (4): 366-76The promyelocytic leukemia protein (PML) is involved in many cellular processes including cell cycle progression, DNA damage response, transcriptional regulation, viral infection, and apoptosis. These cellular activities often rely on the localization of PML to unique subnuclear structures known as PML nuclear bodies (NBs). More than 50 cellular proteins are known to traffic in and out of PML NBs, either transiently or constitutively. In order to understand the dynamics of these NBs, it is important to delineate the regulation of PML itself. PML is subject to extensive regulation at transcriptional, post-transcriptional, and post-translational levels. Many of these modes of regulation depend on the cellular context and the presence of extracellular signals. This review focuses on the current knowledge of regulation of PML under normal cellular conditions as well as the role for regulation of PML in viral infection and cancer.|Animals[MESH]|Cell Nucleus/*metabolism[MESH]|Humans[MESH]|Intranuclear Inclusion Bodies/genetics/*metabolism[MESH]|Nuclear Proteins/genetics/metabolism/physiology[MESH]|Promyelocytic Leukemia Protein[MESH]|Signal Transduction/genetics/physiology[MESH]|Transcription Factors/genetics/metabolism/physiology[MESH]|Tumor Suppressor Proteins/genetics/metabolism/*physiology[MESH] |